C07H17/06

FLUORESCENT PROBE FOR DETECTING CANCER
20220144879 · 2022-05-12 ·

A fluorescent probe is capable of detecting breast cancer, lung cancer, and squamous cell carcinoma. The fluorescent probe is also capable of detecting a benign tumor of a mammary gland. The fluorescent probe includes a compound represented by the following general formula or a salt thereof:

##STR00001##

FLUORESCENT PROBE FOR DETECTING CANCER
20220144879 · 2022-05-12 ·

A fluorescent probe is capable of detecting breast cancer, lung cancer, and squamous cell carcinoma. The fluorescent probe is also capable of detecting a benign tumor of a mammary gland. The fluorescent probe includes a compound represented by the following general formula or a salt thereof:

##STR00001##

Aminocoumarin compounds and methods of their use

Disclosed are aminocoumarin compounds, pharmaceutical compositions containing aminocoumarin compounds, and methods of their use, e.g., in the treatment of a Gram-negative bacterial infection.

AMINOCOUMARIN COMPOUNDS AND METHODS OF THEIR USE
20210009621 · 2021-01-14 ·

Disclosed are aminocoumarin compounds, pharmaceutical compositions containing aminocoumarin compounds, and methods of their use, e.g., in the treatment of a Gram-negative bacterial infection.

PROCESSES FOR MAKING PRMT5 INHIBITORS
20250361258 · 2025-11-27 ·

The disclosure provides processes for preparing the compound of formula (VIa-1) and pharmaceutically acceptable salts thereof. Intermediates useful in preparing the compound of formula (VIa-1) are also provided.

##STR00001##

PROCESSES FOR MAKING PRMT5 INHIBITORS
20250361258 · 2025-11-27 ·

The disclosure provides processes for preparing the compound of formula (VIa-1) and pharmaceutically acceptable salts thereof. Intermediates useful in preparing the compound of formula (VIa-1) are also provided.

##STR00001##